A 12-Week, Multicenter, Safety and Dose-Ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

This study has been completed.

Study NCT00036413 Information provided by Novartis

First Received: May 9, 2002 Last Updated: November 29, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2002
Estimated Primary Completion Date:	No date given